How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used? - NCT00798694-19107 (Clinical Trial 255601)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy255601.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Philadelphia |
|
State:
|
|
PA |
| Zip Code: |
|
19107 |
| Conditions: |
|
Glaucoma |
| Purpose: |
|
The purpose of this research study is to determine whether one glaucoma eye drop is less
likely to cause changes to the surface of the eye (conjunctiva) than another. The
investigators plan to determine this theory by comparing the results when a patient is using
two different prostaglandins, Xalatan or Travatan Z. (Both of these drops are presently on
the market and are approved by the FDA for the treatment of eye pressure). Because this
study will be masked, the clinician who reviews the study results will not know what study
drop each patient has been using.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Age 21 or older
- Able to understand protocol and agree to 3 visits
- Any type of glaucoma
- SLT, ALT, PI accepted
- Naïve: No prior glaucoma treatment (medical or surgical)
- If pt non-compliant, must be off meds 3 months
- Xalatan: At least one month use
Exclusion Criteria:
- Both Groups: Any history of ocular surface disease
- Dry eye syndrome or prior Restasis use
- Prior ocular surgery other than cataract extractions
- Uveitis or other inflammatory disease of the eye or adnexa
- Systemic medications that might influence ocular inflammation
- Any active inflammation or infection
- Pregnancy or intention to become pregnant
- Naïve: Prior use of topical glaucoma med unless off for 3 months.
- Use of preserved artificial tear preparations in last 30 days and more than one year
history of chronic use
- Xalatan: Prior use of Travatan or Travatan Z |
|
|
|
| Study is available at: |
|
Wills Eye Glaucoma Service
Philadelphia, PA 19107
United States
Primary Contact:
Sheryl S Wizov, COA
Email: swizov@willseye.org
Phone: 215-928-3221 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|